Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Nichi-Iko Pharmaceutical Co Ltd
Gross Profit
Nichi-Iko Pharmaceutical Co Ltd
Gross Profit Peer Comparison
Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors
Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
N
|
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
|
Gross Profit
¥4B
|
CAGR 3-Years
-51%
|
CAGR 5-Years
-36%
|
CAGR 10-Years
N/A
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Gross Profit
¥2.8T
|
CAGR 3-Years
9%
|
CAGR 5-Years
14%
|
CAGR 10-Years
9%
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Gross Profit
¥1.2T
|
CAGR 3-Years
24%
|
CAGR 5-Years
16%
|
CAGR 10-Years
7%
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Gross Profit
¥1.5T
|
CAGR 3-Years
14%
|
CAGR 5-Years
11%
|
CAGR 10-Years
4%
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Gross Profit
¥701.1B
|
CAGR 3-Years
11%
|
CAGR 5-Years
17%
|
CAGR 10-Years
11%
|
|
Astellas Pharma Inc
TSE:4503
|
Gross Profit
¥1.3T
|
CAGR 3-Years
9%
|
CAGR 5-Years
5%
|
CAGR 10-Years
5%
|
See Also
What is Nichi-Iko Pharmaceutical Co Ltd's Gross Profit?
Gross Profit
4B
JPY
Based on the financial report for Mar 31, 2022, Nichi-Iko Pharmaceutical Co Ltd's Gross Profit amounts to 4B JPY.
What is Nichi-Iko Pharmaceutical Co Ltd's Gross Profit growth rate?
Gross Profit CAGR 5Y
-36%
Over the last year, the Gross Profit growth was -81%. The average annual Gross Profit growth rates for Nichi-Iko Pharmaceutical Co Ltd have been -51% over the past three years , -36% over the past five years .